Max Robotics — Global Service Robot Directory + US Certification

About

Paolo Prosperi is a surgeon-scientist whose research is reshaping the landscape of minimally invasive endocrine and oncologic surgery. His primary focus lies in advancing adrenal surgery, where he has made landmark contributions by rigorously comparing robotic and laparoscopic approaches. His highly cited 2017 work on adrenalectomy indications and his large international multicenter study (2020, 41 citations) established critical benchmarks for perioperative outcomes, demonstrating the safety and efficacy of robotic techniques. More recently, his 2025 systematic review and meta-analysis specifically addressed the controversial role of robotic adrenalectomy for pheochromocytoma, providing the highest level of evidence to guide clinical decision-making. Beyond adrenal surgery, Prosperi is a pioneer at the intersection of surgery and emerging technology, as seen in his forward-looking work on the "metaverse" in surgery. He is also advancing the frontiers of colorectal oncology, exploring the role of minimally invasive surgery for locally advanced rectal cancer beyond total mesorectal excision. With a growing body of work that combines rigorous evidence synthesis with technological innovation, Prosperi is defining the future of precision, minimally invasive surgical care.